KOL Withdrawn


Well there you have it, after a bit of back and forth Koligo Therapeutics has now officially withdrawn its IPO.

After what seemed like a fair amount of interest from retail investors, it appears that Koligo was unable to attract the level of institutional investment needed to warrant pressing forward, despite having dropped its valuation by 5M back in April.

There were eyebrows raised as to why a US business would opt to list first on the ASX and some noted that perhaps the company wasn’t quite where it needed to be to drum up the interest required back home.

Looks like we wont be seeing a repeat of Exopharm.